Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghayad

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 1, 1986
[Behçet's disease. Apropos of 32 cases]E Bitar, E Ghayad, K Ghoussoub, et al.
Molecular Cancer|November 10, 2010
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cellsAurélie Thollet, Julie A Vendrell, Léa Payen, et al.
Cancers|May 11, 2024
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative RhabdomyosarcomaFarah Ramadan, Raya Saab, Farah Ghamloush, et al.
Cancers|December 23, 2022
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor ProgressionPia Fahmé, Farah Ramadan, Diep Tien Le, et al.
Cells|July 27, 2022
CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in RhabdomyosarcomaAssil Fahs, Nader Hussein, Hasan Zalzali, et al.
International Journal of Cancer|April 5, 2013
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitorPaul Vilquin, Marie Villedieu, Evelyne Grisard, et al.
Translational Psychiatry|March 10, 2023
HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer's diseaseMarie Alexandra Albaret, Julien Textoris, Bastien Dalzon, et al.
Cancer Biology & Therapy|October 12, 2018
The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcomaSandra E Ghayad, Ghina Rammal, Omar Sarkis, et al.
Frontiers in Oncology|October 29, 2020
Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein Content: Implications on Oxidative Stress Protection and Enhanced PlasticityAssil Fahs, Farah Ramadan, Farah Ghamloush, et al.
International Journal of Cancer|October 11, 2015
The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcomaHussein Basma, Sandra E Ghayad, Ghina Rammal, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 1, 1986
[Behçet's disease. Apropos of 32 cases]E Bitar, E Ghayad, K Ghoussoub, et al.
Molecular Cancer|November 10, 2010
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cellsAurélie Thollet, Julie A Vendrell, Léa Payen, et al.
Cancers|May 11, 2024
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative RhabdomyosarcomaFarah Ramadan, Raya Saab, Farah Ghamloush, et al.
Cancers|December 23, 2022
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor ProgressionPia Fahmé, Farah Ramadan, Diep Tien Le, et al.
Cells|July 27, 2022
CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in RhabdomyosarcomaAssil Fahs, Nader Hussein, Hasan Zalzali, et al.
International Journal of Cancer|April 5, 2013
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitorPaul Vilquin, Marie Villedieu, Evelyne Grisard, et al.
Translational Psychiatry|March 10, 2023
HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer's diseaseMarie Alexandra Albaret, Julien Textoris, Bastien Dalzon, et al.
Cancer Biology & Therapy|October 12, 2018
The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcomaSandra E Ghayad, Ghina Rammal, Omar Sarkis, et al.
Frontiers in Oncology|October 29, 2020
Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein Content: Implications on Oxidative Stress Protection and Enhanced PlasticityAssil Fahs, Farah Ramadan, Farah Ghamloush, et al.
International Journal of Cancer|October 11, 2015
The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcomaHussein Basma, Sandra E Ghayad, Ghina Rammal, et al.
Pageof 6